
Need information?
CONTACT US
BIOFIRE® Respiratory 2.1 plus Panel
BIOFIRE FILMARRAY Respiratory Panel
The new BIOFIRE® FILMARRAY® Respiratory 2.1 plus Panel enables rapid and accurate automated detection of pathogens behind respiratory infections. It tests for 19 viruses including SARS-CoV-2, and 4 bacteria that cause respiratory tract infections in 45 min.
- Simple: 2 minutes of hands-on time
- Easy: No precise measuring or pipetting required
- Fast: Turnaround time of 45 minutes for RP2 plus Comprehensive: 23 targets including viruses and bacteria
Do you need more information?
Simple, comprehensive respiratory testing
The BIOFIRE® Respiratory 2.1 plus Panel tests for 19 viruses and 4 bacteria which cause respiratory tract infections with an overall performance: 97.1% sensitivity and 99.3% specificity, SARS-CoV-2 Performance: 98.4% PAA, 98.9% NPA. It works on the BIOFIRE® FILMARRAY® 2.0 and Torch systems, an FDA, CE-IVD, and TGA certified multiplex PCR system. BIOFIRE® FILMARRAY® integrates sample preparation, amplification, detection and analysis into one simple system that requires just 2 minutes of hands-on time, with a total run time of about an 45 minutes. Rapid and accurate identification of the causative agent of upper respiratory tract infections may improve patient management by informing timely and effective antibiotic or antiviral therapy, preventing secondary spread of infection, shortening hospital stays and reducing costs of unnecessary ancillary tests.
- Simple: 2 minutes of hands-on time
- Easy: No precise measuring or pipetting required
- Fast: Turnaround time of about 45 minutes
- Comprehensive: 23 target respiratory panel
BIOFIRE® FILMARRAY® Respiratory 2.1 plus Panel is one of five FDA-cleared and/or CE-marked panels for use on the BIOFIRE® FILMARRAY® multiplex PCR system. Taken together, the five BIOFIRE® FILMARRAY® panels comprise the largest infectious disease pathogen menu commercially available. The other available panels are:
- BIOFIRE® FILMARRAY® ME panel
- BIOFIRE® FILMARRAY® BCID panel
- BIOFIRE® FILMARRAY® GI panel
- BIOFIRE® FILMARRAY® Pneumonia plus Panel
23 targets at once
The BIOFIRE® FILMARRAY® Respiratory 2.1 plus Panel is incredibly comprehensive, with simultaneous testing for 23 of the most common pathogens, including SARS-CoV-2, involved in RTI.
Viruses | Bacteria | ||
Adenovirus Coronavirus 229E Coronavirus HKU1 Coronavirus OC43 Coronavirus NL63 Middle East Respiratory Syndrome CoronaVirus (Mers-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus Human Rhinovirus/Enterovirus |
Influenza A Influenza A/H1 Influenza A/H1-2009 Influenza A/H3 Influenza B Parainfluenza 1 Parainfluenza 2 Parainfluenza 3 Parainfluenza 4 RSV |
Bordetella pertussis Bordetella parapertussis Chlamydophila pneumoniae Mycoplasma pneumoniae |
Panel Specification
Sample Handling | Performance Parameters |
---|---|
Sample Type: Nasopharyngeal Swab | Hands-on time: Approx. 2 minutes |
Sample Volume: 300 μL | Run turnaround time: About an hour |
Our Solutions
- Emergency Department patient management Solutions page
- Antimicrobial Resistance Management Solutions page
Publications
Fast facts on Respiratory Pathogens
What are Respiratory Pathogens?
The vast majority of respiratory illnesses are caused by viruses and bacteria. In both children and adults, acute respiratory infections (ARI) are most frequently due to infections with Influenza A and B viruses, Parainfluenza viruses 1, 2 and 3, Respiratory Syncytial Virus (RSV A and B), Adenoviruses and Rhinoviruses. Others pathogens such as Coronaviruses, Bocaviruses, Enteroviruses, Parainfluenza 4, Human Metapneumovirus, Mycoplasma pneumonia and Chlamydophila pneumoniae also infect the respiratory tract and can cause various diseases from mild self-limiting upper respiratory infections to potentially threatening pneumonia.
Who is most at risk?
Anyone can become infected and ill with these respiratory pathogens. However, young children, the elderly, immunocompromised or weakened individuals (including those with chronic disease, cancer, or in intensive care) are most likely to suffer serious and potentially life-threatening pneumopathies.
What are the benefits of Respiratory pathogens molecular testing?
Clinical symptoms for different respiratory illnesses are similar so in vitro diagnostic molecular methods are necessary to determine the causative agents. Early, rapid and specific detection of the virus or bacteria involved using real-time PCR methods is essential to provide patient-tailored therapy for better outcomes. An accurate diagnosis may also help to control outbreaks, reduce potential antibiotic resistance and facilitate a more rapid patient recovery.
Testimonials
Watch Mr Abdulwahab Al Zahrani’s testimonial on the implementation of the BioFire RP2.1plus panel at the King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia
Technical Notes and Advisory Notes:
- Guidelines for Laboratory Verification of Performance of the BIOFIRE® FILMARRAY® Respiratory Panel (RP)
- Contamination Prevention & Decontamination
- Bordetella pertussis Advisory Notice
Instructions for Use and Manuals:
- BIOFIRE® FILMARRAY® Respiratory 2.1 plus Panel (RP2.1plus) Instruction Booklet, FAIV
Product Support Documents:
- BIOFIRE® FILMARRAY® Respiratory 2.1 plus Panel Quick Guide
EC Declarations of conformity:
Please consult your local bioMérieux representative for product availability in your country
COMPLETE YOUR SOLUTION
- Legal Notice
- Privacy
- Cookie Policy
- Contact
- Sitemap
- Copyright 2022 bioMérieux SA